Management of Gestational Trophoblastic Diseases-An Update

Rev Recent Clin Trials. 2015;10(4):255-62. doi: 10.2174/1574887110666150923111731.

Abstract

Introduction: Gestational trophoblastic disease is a spectrum of neoplastic abnormalities arising from fetal trophoblastic tissue. The range of the diseases in this group varies from relatively benign Hydatidifom mole (complete and partial mole) to highly malignant choriocarcinoma.

Methods: We have reviewed the available literature and discussed the management and follow up based on the current understanding of the natural history, extent and the prognosis of the disease. Key observations: Depending on the underlying pathology the disease can subside, progress or even metastasize and lead to death, if left untreated. The treatment of the disease is relatively simple and the disease is highly curable by single or multi agent chemotherapy. Appropriate and timely treatment not only saves the women from morbidity and death but also can help preserve their fertility.

Conclusions: Management of Gestational disease should ideally be done in a specialized multi-disciplinary environment and the outcome of treatment in majority of the cases is very satisfactory.

Publication types

  • Review

MeSH terms

  • Adult
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Gestational Trophoblastic Disease / mortality
  • Gestational Trophoblastic Disease / pathology*
  • Gestational Trophoblastic Disease / therapy*
  • Humans
  • Hydatidiform Mole / mortality
  • Hydatidiform Mole / pathology
  • Hydatidiform Mole / therapy
  • Hysterectomy / methods
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Pregnancy
  • Prognosis
  • Radiotherapy, Adjuvant
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Uterine Neoplasms / mortality
  • Uterine Neoplasms / pathology*
  • Uterine Neoplasms / therapy